BioAge Labs (BIOA) Other Accumulated Expenses (2023 - 2026)

BioAge Labs has disclosed Other Accumulated Expenses across 4 years of filings, most recently posting $388000.0 for Q2 2026.

• In Q2 2026, Other Accumulated Expenses fell 57.41% year-over-year to $388000.0; the TTM figure through Jun 2026 stood at $388000.0 (down 57.41% YoY), while the FY2025 annual figure was $525000.0, up 25.9% from the prior year.
• Other Accumulated Expenses came in at $388000.0 for Q2 2026 at BioAge Labs, down from $714000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.7 million in Q3 2024 to a low of $388000.0 in Q2 2026.
• Average Other Accumulated Expenses over 4 years is $836444.4, with a median of $714000.0 recorded in 2026.
• Year-over-year, Other Accumulated Expenses tumbled 69.98% in 2024 and climbed 27.96% in 2026.
• Over 4 years, Other Accumulated Expenses stood at $1.4 million in 2023, then plunged by 69.98% to $417000.0 in 2024, then advanced by 25.9% to $525000.0 in 2025, then declined by 26.1% to $388000.0 in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $388000.0 in Q2 2026, $714000.0 in Q1 2026, and $525000.0 in Q4 2025.